Where does Ibis Biosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ibis Biosciences, Inc. ranks #6,154 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ibis Biosciences, Inc. hold?

Ibis Biosciences, Inc. holds 55 US utility patents granted between 2015 and 2022, spanning 18 technology areas.

What is Ibis Biosciences, Inc.'s Innovation Score?

Ibis Biosciences, Inc. has an Innovation Score of 39.5 out of 100 (top 38% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Ibis Biosciences, Inc.'s patent grant rate increasing or decreasing?

Ibis Biosciences, Inc.'s recent grant velocity is -85% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Ibis Biosciences, Inc.'s patents?

Ibis Biosciences, Inc.'s patents average 16.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ibis Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Ibis Biosciences, Inc.

Q: What technology areas does Ibis Biosciences, Inc. focus on?

Ibis Biosciences, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 44 patents, ranking #108 of 2,502 assignees active in that subclass. Grants appear in 18 CPC subclasses total.

USPTO PatentsView assignee record - 55 granted patents across 18 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ibis ranks #6,154 of 49,997 tracked US assignees by granted-patent volume, with 55 patents across 18 technology areas.

#6,154
of 49,997 US assignees by volume: Top 38%
by Innovation Score (39.5/100): 16.4
avg claims per patent: -85%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6154 · US Corporation #6,154 · 55 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 55 grants
UPPER-Q #6,154/49,997
PHOTO-FINISH Gearbox
CPC-FOCUS C12Q · 18 areas
INNOV-THIN 39.5/100
CLAIMS-RICH 16.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -85% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gearbox, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ibis’s 39.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.9 pts (35%) Velocity 0.7 pts (2%) Breadth 15.0 pts (38%) Claim depth 9.8 pts (25%)

Qualcomm Incorporated · highest

85
BGC Partners · near

39
Duraflex Hong Kong · near

39
HP Printing Korea · near

39
Ibis Biosciences · this assignee

39
Landscape Structures · near

39
3D Lighting… · lowest

7

What this shows Ibis's Innovation Score is 39.5/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ibis?

Each dot is one of Ibis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ibis’s own 16.4 claims/patent is ABOVE the 15.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Ibis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ibis's grants concentrate

Ibis Biosciences, Inc. is a focused PatentsView assignee: 18 CPC subclasses with 80% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2015 (13 grants) versus a trough of 1 in 2022. By volume, Ibis sits between Grail, Inc. and International Tobacco Machinery Poland Sp. z o.o..

Ibis's three-year grant acceleration

Ibis Biosciences, Inc. shows 1 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Grail

55
Gearbox

55
George Mason Univ…

55
Hexcel Composites

55
Inscape Data

55
Ipcom & KG

55
Integrated Silico…

55
International Tob…

55
Ibis Biosciences ◀

55

What this shows Ibis holds 55 patents at rank #6,154, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ibis

By rank, the assignees closest to #6,154 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Ibis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Ibis, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Ibis ranks #108 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

HP Printing Korea Co., Ltd. 39 BGC Partners, Inc. 39 Duraflex Hong Kong Limited 39 Landscape Structures Inc. 39

Similar claim depth

Nearest assignees by average claims per patent (16.4 here).

Precision Combustion, Inc. 16.4 avg University College Cardiff Consultants Limited 16.4 avg Tigo Energy, Inc. 16.4 avg Boehringer Ingelheim Animal Health USA Inc. 16.4 avg

Ibis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 38% higher than 62% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Ibis Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	13	23.6%
2016	11	20.0%
2017	12	21.8%
2018	9	16.4%
2019	3	5.5%
2020	6	10.9%
2022	1	1.8%

Which technologies does Ibis Biosciences, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 44

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 16

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 14

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 12

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 9

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 7

H01J - Electric Discharge Tubes OR Discharge Lamps 5

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

Y10T - Technical Subjects Covered BY Former US Classification 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

C07K - Peptides 2

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 1

B66C - CRANES; Load-engaging Elements OR Devices FOR Cranes, Capstans, Winches, OR Tackles 1

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ibis Biosciences, Inc.'s patent record in context - here's where to go next.

Ibis Biosciences, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 80% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #6,154 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ibis Biosciences, Inc. against Grail, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.